CClinicalTrials.gg
CompletedNCT00682487Updated Jun 19, 2009

Hair Cortisol and the Risk of Acute Myocardial Infarction

An observational study in Acute Myocardial Infarction, sponsored by Meir Medical Center. Completed at 1 site in Israel. Open to male participants. Per ClinicalTrials.gov, last updated 2009-06-19.

Sponsored by Meir Medical Center · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
120
Sex
Male
01

Study summary

Aim of the study:

To evaluate whether hair cortisol levels are elevated in patients admitted with acute MI compared to controls.

Study steps:

  1. Introduction of the study to the participants and inform consent signing
  2. Collection of clinical and demographic data
  3. Scalp hair sampling- samples will be sent for laboratory analysis
  4. Analysis of the results
Read the detailed description

Acute physical stressors such as surgery, trauma and intense physical exertion are well-known triggers of cardiovascular events. The connection between acute emotional stress and the heart has been controversial for many years. However, emotional stressors are now increasingly recognized as precipitants of cardiovascular events including myocardial infarction (MI). For example, on the day of the Los Angeles earthquake in 1994 the number of cardiac deaths and hospital admissions for acute myocardial infarction was 2-5 times higher than the usual rate. Furthermore, the risk of myocardial infarction in the short period following an acute emotional stress such as anger outburst, seems to be twice that of other periods and may be a more common precipitant than physical exertion1. While the association between acute stress and cardiovascular mortality and morbidity is well established, controversy still exists whether there is the same association with chronic stress, both physical and emotional. Data regarding this question are extremely limited since there has been no objective and reliable mode for the assessment of physical stress and for the quantification of overall chronic stress. Furthermore, the fact that all the information regarding the association between chronic stress and acute MI derives from retrospective studies further complicates this issue.

Both physical and emotional stress activate several neuroendocrine systems, the most important being the hypothalamic-pituitary-adrenal axis that stimulates the production and secretion of glucocorticoids (especially cortisol) from the adrenal cortex. Therefore, cortisol is considered to be a "stress hormone" and higher levels of serum cortisol have been observed in patients with acute stress such as those presented with acute MI, compared to healthy controls.

Currently, there are several modalities for measuring cortisol levels including serum, urinary and salivary techniques. However, all these methods represent indicators of acute stress and do not reflect accumulation of stress over time.

Recently there has been a growing interest in measuring hair cortisol level. Hair grows approximately 1 centimeter per month, and hair analysis accurately reflects long-term endogenous production of cortisol. This provides for the first time a reliable mode for the measurement of the accumulation of cortisol over time and a potential biomarker of chronic stress. Indeed, several reports have demonstrated an association between high hair cortisol levels and chronic stress in both animal models and in humans. Nevertheless, the possible association between hair cortisol and the risk of acute MI has not been studied yet.

Aim of the study:

To evaluate whether hair cortisol levels are elevated in patients admitted with acute MI compared to controls.

02

Conditions studied

  • Acute Myocardial Infarction

Keywords

  • Myocardial infarction
  • Stress
  • Hair Cortisol
03

In context

Myocardial Infarction

2,744 studies on the registry are indexed under Myocardial Infarction; 418 are open to participants now.

This study's enrollment of 120 is below the median of 500 across 983 observational studies indexed under Myocardial Infarction.

Browse Myocardial Infarction studies →

Lead sponsor

Meir Medical Center is the lead sponsor of 389 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Cases: Patients admitted to the cardiology department due to acute myocardial infarction Controls: Patiens admitted ro an Internal Medicine department due to non-thrombotic disease.

Inclusion criteria

  1. Cases- patients with acute MI ( elevated cardiac enzymes + chest pain or typical ECG changes)
  2. Controls- patients admitted to an internal medicine department due to reasons other than acute MI or stroke.

Exclusion criteria

Exclusion Criteria:

  1. Corticosteroid treatment in the last 12 months
  2. Diagnosis or Cushing's or Addison's disease
  3. Treatment with hormone replacement therapy
  4. Treatment with oral contraceptives
  5. Colored heir
  6. Inability to sign inform consent
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
120 participants (actual)

Groups and cohorts

  • 1

    patients admitted to the cardiology department with acute Myocardial infarction.

    Other: Hair sampling for cortisol

  • 2

    patients admitted to an internal medicine department due to reasons other than an acute thrombotic event

    Other: Hair sampling for cortisol

Interventions

  • OtherHair sampling for cortisol

    Hair sampling for cortisol

  • OtherHair sampling for cortisol

    Hair sampling for cortisol

06

What researchers measure

Primary outcomes

  1. hair cortisol levels in patients admitted with acute MI compared to controls

    Time frame: at enrollment

Secondary outcomes

  1. the association between hair cortisol levels and the prognosis of patients with acute MI.

    Time frame: at enrollment

07

Study locations

1 site
  • Meir Medical Center
    Kfar Sava, Israel
08

References and documents

Publications

  • Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007 Sep 22;370(9592):1089-100. doi: 10.1016/S0140-6736(07)61305-1. Erratum In: Lancet. 2007 Dec 1;370(9602):1828. PubMed 17822755 ↗
  • Yamada J, Stevens B, de Silva N, Gibbins S, Beyene J, Taddio A, Newman C, Koren G. Hair cortisol as a potential biologic marker of chronic stress in hospitalized neonates. Neonatology. 2007;92(1):42-9. doi: 10.1159/000100085. Epub 2007 Mar 14. PubMed 17356304 ↗
  • Sauve B, Koren G, Walsh G, Tokmakejian S, Van Uum SH. Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med. 2007;30(5):E183-91. doi: 10.25011/cim.v30i5.2894. PubMed 17892760 ↗
  • Kalra S, Einarson A, Karaskov T, Van Uum S, Koren G. The relationship between stress and hair cortisol in healthy pregnant women. Clin Invest Med. 2007;30(2):E103-7. doi: 10.25011/cim.v30i2.986. PubMed 17716540 ↗
  • Davenport MD, Tiefenbacher S, Lutz CK, Novak MA, Meyer JS. Analysis of endogenous cortisol concentrations in the hair of rhesus macaques. Gen Comp Endocrinol. 2006 Jul;147(3):255-61. doi: 10.1016/j.ygcen.2006.01.005. Epub 2006 Feb 17. PubMed 16483573 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 19, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00682487
Lead sponsor
Meir Medical Center
First posted
May 22, 2008
Start date
Jun 2008
Primary completion
Apr 2009
Completion
Apr 2009
Last update
Jun 19, 2009

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion